Key takeaways
- Symptoms lead the diagnosis: for women over 45, NICE advises diagnosing perimenopause and menopause from symptoms and menstrual pattern rather than blood tests.
- The right regimen varies: it depends on whether you still have periods, have gone 12 months without one, or have had a hysterectomy.
- Body-identical HRT is common: transdermal oestrogen with micronised progesterone is a widely used combination, and transdermal oestrogen is not linked to the extra clot risk of oral oestrogen.
- Look for safe care: CQC registration, UK-registered prescribers, a video consultation for new patients and, with your consent, sharing details with your NHS GP.
- Follow-up matters: expect a review about 12 weeks after starting or changing a dose, then at least every 12 months.
What Happens to Hormones in Your 40s?
Perimenopause typically begins during a woman's early to mid-40s, although it can start earlier. Unlike postmenopause, where hormones level out at a steady low baseline, perimenopause is characterised by sharp, unpredictable fluctuations.
During this stage of life:
- Progesterone Declines First: Often resulting in shortened menstrual cycles, heavier or erratic bleeding, fluid retention, breast tenderness, and disrupted sleep.
- Oestrogen Spikes and Plummets: These erratic swings trigger classic vasomotor symptoms (hot flushes and night sweats), alongside mood dips, brain fog, fatigue, palpitations, and joint aches.
- Androgens (Testosterone) Taper Off: Contributing to reduced stamina, loss of lean muscle mass, cognitive fatigue, and low libido.
Because hormone levels fluctuate widely from day to day, a single blood test (such as FSH) is rarely helpful in women over 45. NICE guideline NG23 advises diagnosing perimenopause and menopause from symptoms and menstrual pattern in women aged over 45 without another cause. A clinician may consider tests for women aged 40 to 45 with menopausal symptoms, or under 40.
What Online HRT Options Suit Women Over 40?
Hormone therapy is never one-size-fits-all. The right regimen depends on your age, whether you still have your womb, and whether you are having regular, irregular, or no periods.
| Clinical Situation | Recommended Regimen | How It Works | Common Formulations |
|---|
| Still having periods (Perimenopausal) | Sequential (Cyclical) Combined HRT | Daily oestrogen, with progestogen added for 12 to 14 days each month to protect the womb lining while producing a regular bleed | Body-identical transdermal estradiol (gel, patch, or spray) paired with micronised progesterone capsules (e.g. Utrogestan) |
|---|
| No periods for 12+ months (Postmenopausal) | Continuous Combined HRT | Fixed daily doses of both oestrogen and progestogen taken together without breaks; designed to be completely bleed-free | Combined daily patches (e.g. Evorel Conti), oral tablets, or transdermal oestrogen with daily micronised progesterone |
|---|
| Hysterectomy (Womb removed) | Oestrogen-Only HRT | Daily oestrogen replacement alone. Without a womb lining (endometrium) to protect, progestogen is not required | Transdermal estradiol gels (e.g. Oestrogel), sprays (e.g. Lenzetto), patches (e.g. Evorel), or oral tablets |
|---|
| Vaginal dryness, discomfort, or recurrent UTIs | Localised Vaginal Oestrogen | Very low-dose topical oestrogen applied directly within the vagina; negligible absorption into the bloodstream | Pessaries (e.g. Vagifem), vaginal creams (e.g. Ovestin), or localised vaginal rings |
|---|
Why Body-Identical Hormones Lead Modern Prescribing
At PrivateDoc, our clinicians prioritise modern body-identical hormones, which match the exact molecular structure of human ovarian hormones:
- Transdermal 17-beta estradiol (gels, patches, sprays): Absorbed directly through the skin into the bloodstream, bypassing first-pass liver metabolism. NICE notes that transdermal HRT is not linked to an increased risk of venous blood clots (VTE) at standard doses, unlike oral oestrogen, so it is often preferred for women with a higher BMI or other clot risk factors. Your clinician will check what suits you.
- Micronised progesterone (e.g. Utrogestan): A capsule, usually taken at bedtime, that protects the womb lining when you take oestrogen.
How Online HRT Consultations Work with PrivateDoc
Accessing prescription hormone therapy online must always be grounded in safety. It should never be an unmonitored checkout process. Safe, regulated care involves structured clinical interactions governed by the Care Quality Commission (CQC) and General Medical Council (GMC).
Step 1: Detailed Digital Health Assessment
You begin by completing an in-depth clinical questionnaire covering your menstrual patterns, symptom severity, current medications, blood pressure readings, and family medical background.
Step 2: Face-to-Face Video Consultation
PrivateDoc starts new HRT with a video consultation. Meeting a UK-registered clinician by video lets them verify your identity, assess your symptoms as a whole, explain the benefits and risks of treatment and answer your questions before prescribing.
Step 3: Discreet home delivery
Once prescribed, your medication is dispensed by our licensed UK pharmacy partner and sent in discreet packaging to your door. Stock of individual HRT products can vary, and if one is unavailable your clinician can suggest a suitable alternative.
Step 4: Coordinated Primary Care
Responsible digital healthcare providers work alongside the NHS. With your consent, PrivateDoc shares consultation and prescription summaries with your NHS GP surgery, keeping your electronic health record accurate and synchronised.
Why Menopause Care Requires Ongoing Follow-Up
Starting HRT is not an isolated transaction; it is an ongoing therapeutic journey. As natural ovarian output changes, your body absorbs and metabolises hormones differently.
According to guidelines from the British Menopause Society (BMS) and NICE (NG23), structured follow-up care is essential for four main reasons:
1. Assessing Symptom Control
Hormone replacement takes time to establish equilibrium. While symptoms like hot flushes often start improving within 2 to 4 weeks, mood stability, joint comfort, tissue recovery, and brain fog can take up to 12 weeks. An initial review confirms whether your symptoms have cleared or if your dose needs adjusting.
2. Managing Early Side Effects
Mild side effects like breast tenderness, temporary nausea, or breakthrough spotting can happen during the first few weeks as tissues adapt to oestrogen. A clinician-led review helps determine whether these are settling naturally or if a change in formulation or delivery method is warranted.
3. Monitoring Health Markers
Ongoing care ensures essential health parameters remain within safe ranges. This includes monitoring blood pressure, tracking body mass index (BMI), reviewing personal or family health changes, and evaluating bleeding profiles.
4. Adjusting Dosages Safely
Finding the right balance requires patience. The goal is to identify the lowest effective dose that controls your symptoms while protecting bone density and cardiovascular health.
What Does an Online Follow-Up Involve?
The Critical 12-Week (3-Month) Review
Clinical consensus recommends a structured clinical review roughly 12 weeks after starting HRT or changing a dose.
During your 3-month online review, your clinician evaluates your progress:
- If hot flushes, night sweats, or poor sleep persist, your transdermal oestrogen dose may be stepped up.
- If you experience ongoing breast tenderness, fluid retention, or headaches, your prescriber may modify the delivery method or lower the dose.
- If you experience premenstrual-like mood dips during the days you take progestogen, your clinician can explore alternative progestogen options or discuss a continuous regimen if appropriate.
Annual Clinical Monitoring
Once you are established on a stable, well-tolerated regimen, BMS guidelines advise that women undergo a clinical review at least once every 12 months.
During this annual consultation, your clinician will:
- Re-evaluate your overall health, checking for any newly diagnosed conditions or new medications.
- Verify current blood pressure and BMI readings.
- Assess bleeding patterns. Unscheduled bleeding is common in the first 3 to 6 months of continuous combined HRT, but new or persistent bleeding after 6 months requires formal clinical investigation.
- Review your long-term risk-versus-benefit profile as you age, ensuring treatment continues to support your quality of life.
On-Demand Clinical Support via the PrivateDoc Patient App
Between formal reviews, unexpected questions or symptoms can still arise. Rather than waiting weeks for a callback, PrivateDoc patients can use the PrivateDoc Patient App to track their treatment and message our clinical team.
Common Signs That Your HRT Needs Adjusting
During your check-ins, your clinician will look for signs that your dose or administration route needs fine-tuning:
Signs Your Oestrogen Dose May Be Too Low
- Flushes, night sweats, or daytime chills begin creeping back.
- Brain fog, low daytime energy, and memory lapses continue past the 12-week mark.
- Persistent low mood, mood swings, or heightened irritability.
- Continued poor sleep due to early morning or middle-of-the-night waking.
Signs Your Oestrogen Dose May Be Too High
- Persistent, uncomfortable breast tenderness or swelling.
- Noticeable fluid retention or swelling in fingers and ankles.
- Nausea or new onset of headaches.
Signs Your Progestogen Requires Review
- Cyclical mood dips, irritability, or anxiety specifically during the days you take progestogen.
- Persistent, erratic unscheduled bleeding after more than 6 months of continuous therapy.
Regulated Safety Standards That Protect You
When choosing an online clinic for menopause care, verifying clinical standards is vital for patient safety.
Ensure your provider meets these core requirements:
- CQC Registration: The service must be registered with the Care Quality Commission in England (or equivalent bodies in Scotland and Wales). This helps ensure that clinical protocols, safeguarding procedures, and prescribing audits meet national healthcare standards.
- GMC and GPhC Licensed Prescribers: Prescriptions should only be issued by registered UK doctors or independent prescribers, dispensed by a General Pharmaceutical Council registered pharmacy.
- Mandatory Identity and Baseline Vetting: A trustworthy service should confirm your identity and check an up-to-date blood pressure reading and your BMI before issuing systemic hormones.
- Transparent Follow-Up Channels: You should always have access to clinical support and medical follow-up should you experience side effects or need advice.
Next step
If you are ready to talk to a clinician about HRT, start your online consultation. We will review your symptoms, health history and blood pressure, and plan your follow-up from the start.
